Ken Lee

Track

Insider profile

Currently holds positions in BioCryst Pharmaceuticals Inc, Hyperion DeFi Inc, POZEN Inc and Old API Wind-Down Ltd

Performance

Overall performance
1.6
Performance over holding periods
1.6
30 days 90 days 120 days
Average return -15% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
4 100% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance

Positions

Position Company Period
Independent Director BioCryst Pharmaceuticals Inc June 27, 2011 -
Independent Director Hyperion DeFi Inc March 26, 2018 -
Lead Independent Director POZEN Inc Jan. 1, 2005 -
Lead Independent Director Old API Wind-Down Ltd Feb. 5, 2016 -
Independent Director Maxygen Inc Sept. 17, 2009 - Aug. 29, 2013
Ken Lee's trades of Hyperion DeFi Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
371.94
Quantity 55,767 +16.4%
Value US$370,421
Transaction date
Purchase
Price
122.26
Quantity 15,840 -45.3%
Value US$3,085,075
Transaction date
Purchase
Price
278.29
Quantity 40,190 -27.5%
Value US$495,974
Transaction date
Purchase
Price
5.38
Quantity 2,000 +10.3%
Value US$10,760
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2022-05-23 2022-05-19
B Purchase
55,767 +16.4%
371.94
US$370,421 		55,767 +16.4% 371.94 US$370,421
2021-06-15 2021-06-15
B Purchase
15,840 -45.3%
122.26
US$3,085,075 		15,840 -45.3% 122.26 US$3,085,075
2021-06-15 2021-06-14
B Purchase
40,190 -27.5%
278.29
US$495,974 		40,190 -27.5% 278.29 US$495,974
2021-06-15 2021-06-11
B Purchase
2,000 +10.3%
5.38
US$10,760 		2,000 +10.3% 5.38 US$10,760